4.7 Article

Genosensors, a nanomaterial-based platform for microRNA-21 detection, non-invasive methods in early detection of cancer

期刊

CLINICA CHIMICA ACTA
卷 530, 期 -, 页码 27-38

出版社

ELSEVIER
DOI: 10.1016/j.cca.2022.02.012

关键词

Tumor suppressor; Carcinogenesis; miR-21; Biosensors

向作者/读者索取更多资源

MicroRNAs are small non-coding RNAs, with miR21 being highly expressed in many mammalian cells and regulating various biological functions. Accurate detection of miR-21 is crucial, and conventional methods have limitations. Advanced techniques such as nanotechnology and biosensors have gained attention in recent years.
MicroRNAs are small non-coding RNAs that are 18-24 nucleotides in length. Among the most widely studied microRNAs, microRNA21 (miR21) is highly expressed in many mammalian cell types. It regulates numerous biological functions such as differentiation, proliferation, apoptosis, and migration. Therefore, sensitive and specific detection of miR-21 is crucial in medical approaches. Several methods such as ISH, northern blotting, RTPCR, microarray, and next-generation are conventionally used to detect miR-21. Due to the limitations and problems related to routine methods, the development of advanced and modern methods has been one of the investigation goals of researchers in recent years. Nanotechnology-based methods have been among the most critical methods in the last two decades. Biosensors are one of the primary modern methods that largely overcome the limitations of routine procedures. The present study introduces and discusses routine methods for the detection of miR-21and the related up-to-date biosensors developed in recent years (2019-2021).

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

Sensitive electrochemical recognition of a-synuclein protein in human plasma samples using bioconjugated gold nanoparticles: An innovative immuno-platform to assist in the early stage identification of Parkinson's disease by biosensor technology

Esmaeil Darvish Aminabad, Mohammad Hasanzadeh, Ali Ahmadalipour, Tohid Mahmoudi, Mohammad Ali Hosseinpour Feizi, Reza Safaralizadeh, Ahmad Mobed

Summary: This research work developed an electrochemical immunosensor for the selective recognition of SNCA in human biofluids. It proposed an innovative protocol for the green synthesis of AuNPs@DMGO and designed a sandwich immunosensor for the sensitive identification of SNCA antigen. The method showed a potential of employment in clinical applications and high-throughput screening of Parkinson's disease using POC.

JOURNAL OF MOLECULAR RECOGNITION (2023)

Review Pharmacology & Pharmacy

Tau Protein Biosensors in the Diagnosis of Neurodegenerative Diseases

Jafar Sadeghzadeh, Parviz Shahabi, Mehdi Farhoudi, Abbas Ebrahimi-Kalan, Ahmad Mobed, Kourosh Shahpasand

Summary: Tau protein is crucial in diagnosing neurodegenerative diseases, but detecting it on a nanoscale is challenging. Methods like ELISA, western-blotting, and molecular-based techniques have limitations. Biosensors are a promising approach to overcome these limitations and monitor tau protein.

ADVANCED PHARMACEUTICAL BULLETIN (2023)

Review Microbiology

Microbiota-Pain Association; Recent Discoveries and Research Progress

Naser Alizadeh, Ghazal Naderi, Mohammad Saeed Kahrizi, Tannaz Haghgouei, Ahmad Mobed, Mehran Ebrahimi Shah-abadi

Summary: The relationship between gut microbiota and pain has gained attention, with evidence suggesting that microbiota is an important pain modulator in the central and peripheral nervous systems. Changes in microbiota through diet or antibiotic mediation may offer a novel therapeutic strategy for pain management.

CURRENT MICROBIOLOGY (2023)

Article Materials Science, Multidisciplinary

Biosensors: The nanomaterial-based method in detection of human gut microbiota

Mohammad Hossein Ayati, Mostafa Araj-Khodaei, Tannaz Haghgouei, Ali Ahmadalipour, Ahmad Mobed, Sarvin Sanaie

Summary: The gut microbiota plays an important role in clinical oncology, affecting not only the risks and causes of cancer, but also the immune response of intestinal and extra-intestinal tumors. Nanomaterial-based biosensors show potential in monitoring and detecting probiotics for quality and safety management. However, point-of-care biosensors specifically for detecting microbial community disruptions in the human gut flora are not yet available in clinical practice.

MATERIALS CHEMISTRY AND PHYSICS (2023)

Article Biochemical Research Methods

Label-free immunosensing of telomerase using bio-conjugation of biotinylated antibody to poly(chitosan) gold nanoparticles

Ahmad Mobed, Fereshteh Kohansal, Sanam Dolati, Mohammad Hasanzadeh

Summary: The aim of this study was to develop a label-free electrochemical biosensor for detecting telomerase in human biofluid. A green nanocomposite (poly[chitosan] decorated by gold nanoparticles) was used to immobilize the biotinylated antibody of telomerase and the immunocomplex of antigen-antibody. The constructed immunosensor showed a wide dynamic range (0.078-160 IU/ml(-1)) with a low limit of quantification of 0.078 IU/ml(-1), providing a unique approach for telomerase assays in early cancer prognosis.

BIOANALYSIS (2023)

Review Engineering, Biomedical

Biosensors; noninvasive method in detection of C-reactive protein (CRP)

Hamidreza Hassanzadeh Khanmiri, Fatemeh Yazdanfar, Ahmad Mobed, Fatemeh Rezamohammadi, Mehrnoush Rahmani, Tannaz Haghgouei

Summary: Early diagnosis of CRP is crucial for effective treatment of related diseases. Current diagnostic techniques, mostly used in central laboratories, are expensive, time-consuming, and require specialized personnel. Point-of-care (POC) biosensors have emerged as a promising alternative, allowing regular health monitoring without laboratory tests.

BIOMEDICAL MICRODEVICES (2023)

Review Cell Biology

Biosensors, Recent Advances in Determination of BDNF and NfL

Ahmad Mobed, Saeid Charsouei, Yalda Yazdani, Morad Kohandel Gargari, Ali Ahmadalipour, Seyyedeh Reyhaneh Sadremousavi, Maryam Farrahizadeh, Ali Shahbazi, Maryam Haghani

Summary: Key biomarkers like BDNF and NfL are crucial for the development and progression of neurological diseases. The discovery of robust biomarkers is important for early detection and monitoring of these diseases. Recent advances in biotechnology and nanotechnology have allowed for real-time detection of multiple biomarkers, making screening programs and personalized medicine possible.

CELLULAR AND MOLECULAR NEUROBIOLOGY (2023)

Review Cell Biology

The Impact of Cerebral Ischemia on Antioxidant Enzymes Activity and Neuronal Damage in the Hippocampus

Jafar Sadeghzadeh, Leila Hosseini, Ahmad Mobed, Hamid Soltani Zangbar, Jaber Jafarzadeh, Jamshid Pasban, Parviz Shahabi

Summary: Cerebral ischemia and subsequent reperfusion can lead to reduced blood supply to specific brain areas, resulting in neurological damage and irreversible harm. The hippocampus is particularly vulnerable to ischemia-induced injuries, with the extent of damage influenced by the different stages of ischemia. Intricate biochemical reactions involving free radicals, oxidative stress, inflammatory responses, and glutamate toxicity contribute to various changes and damage in neural tissue. Antioxidant enzymes play a crucial role in preventing hippocampal damage caused by oxidative stress.

CELLULAR AND MOLECULAR NEUROBIOLOGY (2023)

Article Chemistry, Analytical

Biosensing of telomerase antigen using sandwich type immunosensor based on poly(?-Cyclodextrin) decorated by Au@Pt nanoparticles: An innovative immune-platform toward early-stage identification of cancer

Fereshteh Kohansal, Ahmad Mobed, Nastaran Aletaha, Kambiz Ghaseminasab, Sanam Dolati, Mohammad Hasanzadeh

Summary: A novel sandwich-type electrochemical immunosensor was developed for efficient detection of telomerase antigen. The sensor exhibited excellent selectivity and stability for telomerase detection in human plasma samples, showing great potential for clinical diagnosis of cancer.

MICROCHEMICAL JOURNAL (2023)

Article Chemistry, Analytical

An Innovative Electrochemical Immuno-Platform for Monitoring Chronic Conditions Using the Biosensing of Hyaluronic Acid in Human Plasma Samples

Ahmad Mobed, Fereshteh Kohansal, Sanam Dolati, Mohammad Hasanzadeh, Seyed Kazem Shakouri

Summary: Hyaluronic acid (HA) is a glycosaminoglycan that is synthesized by connective tissue cells and plays a critical role in tissue fibrosis and tumor progression. This study developed an immune device for the sensitive detection of HA in human plasma samples using an innovative alloy substrate. The developed immunosensor has a linear response within a specific concentration range and offers a promising technique for the early diagnosis of disorders related to abnormal levels of HA.

CHEMOSENSORS (2023)

Review Multidisciplinary Sciences

Nanosensors in the detection of antihypertension drugs, a golden step for medication adherence monitoring

Ahmad Mobed, Sarah Gholami, Amir Tahavvori, Farhood Ghazi, Zahra Masoumi, Iraj Alipourfard, Ramtin Naderian, Mehran Mohammadzadeh

Summary: This study reviews the latest biosensors developed for the detection of antihypertensive drugs (AHTDs). Biosensors have been widely used for detecting biomarkers and drugs due to their inherent advantages. Through this study, readers will gain a deeper understanding of biosensors as advanced diagnostic tools.

HELIYON (2023)

Review Medical Laboratory Technology

Advances in human reproductive biomarkers

Ahmad Mobed, Bita Abdi, Sajjad Masoumi, Mohammad Mikaeili, Elham Shaterian, Hamed Shaterian, Esmat Sadat Kazemi, Mahdiye Shirafkan

Summary: Reproductive biomarkers play important regulatory roles in women. The discovery and quantification of these biomarkers are clinically significant. Various detection strategies, including nanotechnology-based methods, have been developed. This article provides an in-depth introduction to the latest advances in biosensor and nanosensor research for detecting and quantitatively identifying reproductive biomarkers.

CLINICA CHIMICA ACTA (2024)

Article Materials Science, Biomaterials

Biosensor-Based Nanodiagnosis of Carcinoembryonic Antigen (CEA): an Approach to Classification and Precise Detection of Cancer Biomarker

Maryam Hariri, Vahid Alivirdiloo, Nastaran Safavi Ardabili, Sarah Gholami, Sajjad Masoumi, Mohammad Reza Mehraban, Mahsa Alem, Reza Shah Hosseini, Ahmad Mobed, Farhood Ghazi, Iraj Alipourfard

Summary: The precise detection of cancer biomarkers is crucial for effective diagnosis, monitoring, and treatment. CEA, a protein found in minimal amounts in adult blood, can be elevated in certain diseases and types of cancer. It is important to develop a sensitive and simple CEA detection method to accurately diagnose cancer and improve patient survival. Biosensors show promise as a new direction in medical oncology, offering rapid response, high sensitivity, and convenience in early disease detection.

BIONANOSCIENCE (2023)

Article Chemistry, Multidisciplinary

A novel portable immuno-device for the recognition of lymphatic vessel endothelial hyaluronan receptor-1 biomarker using GQD-AgNPrs conductive ink stabilized on the surface of cellulose

Ahmad Mobed, Fereshteh Kohansal, Sanam Dolati, Mohammad Hasanzadeh

Summary: LYVE-1 is a hyaluronan receptor expressed on lymphatic vessel endothelium, involved in tumor cell adhesion and lymphocyte passage through the lymphatics. A paper-based electrochemical immune-platform was developed for the recognition of LYVE-1, featuring small size, low cost, high stability, and sensitivity. This biosensor has potential applications in tumor lymphangiogenesis research and biomarker-related disease screening in clinical studies.

RSC ADVANCES (2023)

Article Chemistry, Multidisciplinary

An innovative electrochemical immuno-platform towards ultra-sensitive monitoring of 2-arachidonoyl glycerol in samples from rats with sleep deprivation: bioanalysis of endogenous cannabinoids using biosensor technology

Fereshteh Kohansal, Ahmad Mobed, Rana Ansari, Mohammad Hasanzadeh, Ali Ahmadalipour, Nasrin Shadjou

Summary: The endocannabinoid system is crucial for regulating cognitive and physiological processes, with 2-AG being one of the key endocannabinoids. Rapid and specific diagnosis of 2-AG is important in medical neuroscience and has been a focus of recent research. In this study, a novel immunosensor was developed for quantifying 2-AG, demonstrating high sensitivity and specificity.

RSC ADVANCES (2022)

Article Medical Laboratory Technology

Clinical and genetic analysis of 26 Chinese patients with neonatal intrahepatic cholestasis due to citrin deficiency

Jiansheng Lin, Weihua Lin, Yiming Lin, Weilin Peng, Zhenzhu Zheng

Summary: This study retrospectively analyzed the cases of Chinese infants with NICCD and identified multiple genetic mutations. The study also found comorbidity of NICCD and other inborn errors of metabolism in some patients.

CLINICA CHIMICA ACTA (2024)

Review Medical Laboratory Technology

M-protein detection by mass spectrometry for minimal residual disease in multiple myeloma

Lihua Guan, Wei Su, Jian Zhong, Ling Qiu

Summary: Multiple myeloma is characterized by excessive production of monoclonal immunoglobulins. Routine screening methods are insufficient for detecting low levels of M proteins, but advances in mass spectrometry enable reliable detection of low abundance serum biomarkers for minimal residual disease assessment in multiple myeloma.

CLINICA CHIMICA ACTA (2024)

Article Medical Laboratory Technology

Identification of an association between coronary heart disease and ITGB2 methylation in peripheral blood by a case-control study

Liya Zhu, Chao Zhu, Jialie Jin, Jinxin Wang, Xiaojing Zhao, Rongxi Yang

Summary: This study found an association between blood-based ITGB2 methylation and coronary heart disease (CHD), with hypomethylation of ITGB2 being a risk factor for CHD. Additionally, the combination of ITGB2 methylation and conventional CHD risk factors could efficiently discriminate CHD patients from controls.

CLINICA CHIMICA ACTA (2024)

Article Medical Laboratory Technology

The impact of saliva collection methods on measured salivary biomarker levels

H. Al Habobe, E. B. Haverkort, K. Nazmi, A. P. Van Splunter, R. H. H. Pieters, F. J. Bikker

Summary: Saliva diagnostics have become popular due to their non-invasive nature and patient-friendly collection process. However, the choice of saliva collection method can affect the measured levels of various biomarkers.

CLINICA CHIMICA ACTA (2024)

Article Medical Laboratory Technology

Sex-related differences in within-subject biological variation estimates for 22 essential and non-essential amino acids

Abdurrahman Coskun, Anna Carobene, Ozlem Demirelce, Michele Mussap, Federica Braga, Ebru Sezer, Aasne Karine Aarsand, Sverre Sandberg, Pilar Fernandez Calle, Jorge Diaz-Garzon, Metincan Erkaya, Cihan Coskun, Esila Nur Erol, Hunkar Dag, Bill Bartlett, Mustafa Serteser, Niels Jonker, Ibrahim Unsal

Summary: In this study, BV estimates for 22 AAs were provided based on a large sample size, and it was found that there are differences in CVI estimates between males and females for most AAs, which has implications for the clinical interpretation and use of AAs.

CLINICA CHIMICA ACTA (2024)

Review Medical Laboratory Technology

Genomic profile of Parkinson's disease in Asians

Valentinus Besin, Farizky Martriano Humardani, Trilis Yulianti, Matthew Justyn

Summary: The study of Parkinson's Disease in Asian populations has revealed the impact of genetic variants on multiple biological pathways and highlighted shared genetic susceptibility with other diseases. These findings emphasize the importance of personalized treatment based on individual genetic profiles.

CLINICA CHIMICA ACTA (2024)

Review Medical Laboratory Technology

Prediction of atherosclerotic cardiovascular risk in early childhood

Simona Ferraro, Sara Benedetti, Savina Mannarino, Santica Marcovina, Elia Mario Biganzoli, Gianvincenzo Zuccotti

Summary: Risk stratification for cardio-vascular disease should be implemented in childhood to promote early prevention strategies, as atherosclerotic lesions can be present even in very young individuals. Evaluating pediatric CV risk factors/clinical conditions and conducting lipid profile and genetic testing can help identify children at risk of future CV events and guide appropriate therapeutic options.

CLINICA CHIMICA ACTA (2024)

Review Medical Laboratory Technology

Advances in human reproductive biomarkers

Ahmad Mobed, Bita Abdi, Sajjad Masoumi, Mohammad Mikaeili, Elham Shaterian, Hamed Shaterian, Esmat Sadat Kazemi, Mahdiye Shirafkan

Summary: Reproductive biomarkers play important regulatory roles in women. The discovery and quantification of these biomarkers are clinically significant. Various detection strategies, including nanotechnology-based methods, have been developed. This article provides an in-depth introduction to the latest advances in biosensor and nanosensor research for detecting and quantitatively identifying reproductive biomarkers.

CLINICA CHIMICA ACTA (2024)

Article Medical Laboratory Technology

A pilot study of newborn screening for X-linked adrenoleukodystrophy based on liquid chromatography-tandem mass spectrometry method for detection of C26:0-lysophosphatidylcholine in dried blood spots: Results from 43,653 newborns in a southern Chinese population

Chengfang Tang, Fang Tang, Yanna Cai, Minyi Tan, Sichi Liu, Ting Xie, Xiang Jiang, Yonglan Huang

Summary: This study proposes an effective method for screening X-ALD and evaluates the performance of newborn screening for X-ALD in Guangzhou. The LC-MS/MS method can accurately identify X-ALD through analysis of C26:0-LPC.

CLINICA CHIMICA ACTA (2024)

Article Medical Laboratory Technology

Prenatal prevalence and postnatal manifestations of 16p11.2 deletions: A new insights into neurodevelopmental disorders based on clinical investigations combined with multi-omics analysis

Lan Liu, Jiamin Wang, Xijing Liu, Jing Wang, Lin Chen, Hongmei Zhu, Jingqun Mai, Ting Hu, Shanling Liu

Summary: The 16p11.2 deletion is a common genetic cause of neurodevelopmental disorders, with prenatal and postnatal presentations including vertebral malformations and language impairment. The majority of deletions are de novo and may be associated with MAPK3 and histidine-associated metabolism.

CLINICA CHIMICA ACTA (2024)

Article Medical Laboratory Technology

Prospectives and retrospectives of microfluidics devices and lab-on-A-chip emphasis on cancer

Sneha Venkatesalu, Shanmugapriya Dilliyappan, Avanthika Satish Kumar, Thirunavukkarasu Palaniyandi, Gomathy Baskar, Maddaly Ravi, Asha Sivaji

Summary: Microfluidics is a science and technology that deals with less sample-to-more precision in vitro analysis. It has wide applications in cancer theranostics, enabling precise diagnosis and personalized treatment.

CLINICA CHIMICA ACTA (2024)

Review Medical Laboratory Technology

Genetics of congenital heart disease

Yuanqin Zhao, Wei Deng, Zhaoyue Wang, Yanxia Wang, Hongyu Zheng, Kun Zhou, Qian Xu, Le Bai, Huiting Liu, Zhong Ren, Zhisheng Jiang

Summary: The cardiovascular system and the central nervous system exhibit a coordinated developmental process during embryonic development. Congenital heart disease (CHD) is the most common congenital disorder, and neurodevelopmental disorders (NDD) are common complications in CHD patients. Both genetic and non-genetic factors contribute to the co-occurrence of CHD and NDD. Further research should focus on identifying common molecular mechanisms underlying this co-occurrence and promoting the research and treatment of developmental disorders related to the cardiovascular and central nervous systems.

CLINICA CHIMICA ACTA (2024)

Article Medical Laboratory Technology

Flow cytometry in the detection of circulating tumor cells in neoplastic effusions

Karol Gostomczyk, Ewelina Lukaszewska, Jedrzej Borowczak, Anita Bator, Marek Zdrenka, Magdalena Bodnar, Lukasz Szylberg

Summary: Flow cytometry improves the detection of epithelial cancer cells in peritoneal and pleural fluids compared to conventional cytology. Due to similar speciflcity and higher sensitivity, flow cytometry offers a promising alternative to cytology for patient screening.

CLINICA CHIMICA ACTA (2024)

Article Medical Laboratory Technology

Usability of serum inter-α-trypsin inhibitor heavy chain 4 as a biomarker for assessing severity and predicting functional outcome after human aneurysmal subarachnoid hemorrhage: A prospective observational cohort study at a single institution

Heping Tian, Genghuan Wang, Qi Zhong, Haihang Zhou

Summary: This study found that the decline of serum ITIH4 concentrations during the early phase after aneurysmal subarachnoid hemorrhage (aSAH) was closely related to the severity and poor prognosis of the disease. Serum ITIH4 may represent a promising prognostic biomarker of aSAH.

CLINICA CHIMICA ACTA (2024)

Article Medical Laboratory Technology

Accurate identification of HLA-B*15:02 allele by two-dimensional polymerase chain reaction

Xueting Zhu, Yang Yu, Jun Zhang, Yuxia Zhan, Guanghua Luo, Lu Zheng

Summary: This study successfully established a 2D-PCR method for identifying HLA-B*15:02 through a two-tube reaction. This method can distinguish HLA-B*15:02 from 16 highly homologous HLA-B*15 alleles. Among 1830 samples from the clinical general population, 3 HLA-B*15:02 homozygotes and 84 HLA-B*15:02 heterozygotes were detected.

CLINICA CHIMICA ACTA (2024)